Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Other Non-Current Assets (2016 - 2026)

Conmed filings provide 17 years of Other Non-Current Assets readings, the most recent being $151.7 million for Q1 2026.

  • On a quarterly basis, Other Non-Current Assets rose 19.38% to $151.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $151.7 million, a 19.38% increase, with the full-year FY2025 number at $150.5 million, up 29.34% from a year prior.
  • Other Non-Current Assets hit $151.7 million in Q1 2026 for Conmed, up from $150.5 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $151.7 million in Q1 2026 to a low of $93.9 million in Q4 2022.
  • Median Other Non-Current Assets over the past 5 years was $108.0 million (2024), compared with a mean of $117.9 million.
  • Biggest five-year swings in Other Non-Current Assets: fell 4.98% in 2022 and later soared 37.84% in 2025.
  • Conmed's Other Non-Current Assets stood at $93.9 million in 2022, then grew by 2.38% to $96.1 million in 2023, then rose by 21.07% to $116.4 million in 2024, then rose by 29.34% to $150.5 million in 2025, then rose by 0.82% to $151.7 million in 2026.
  • The last three reported values for Other Non-Current Assets were $151.7 million (Q1 2026), $150.5 million (Q4 2025), and $148.3 million (Q3 2025) per Business Quant data.